...
首页> 外文期刊>JAMA internal medicine >Association of a Workplace Sales Ban on Sugar-Sweetened Beverages With Employee Consumption of Sugar-Sweetened Beverages and Health
【24h】

Association of a Workplace Sales Ban on Sugar-Sweetened Beverages With Employee Consumption of Sugar-Sweetened Beverages and Health

机译:糖甜饮料与糖甜饮料和健康的糖果消耗的工作场所销售禁令协会

获取原文
获取原文并翻译 | 示例
           

摘要

Importance Reductions in sugar-sweetened beverage (SSB) intake can improve health, but are difficult for individuals to achieve on their own. Objectives To evaluate whether a workplace SSB sales ban was associated with SSB intake and cardiometabolic health among employees and whether a brief motivational intervention provides added benefits to the sales ban. Design, Setting, and Participants This before-after study and additional randomized trial conducted from July 28, 2015, to October 16, 2016, at a Northern California university and hospital assessed SSB intake, anthropometrics, and cardiometabolic biomarkers among 214 full-time English-speaking employees who were frequent SSB consumers (>= 360 mL [>= 12 fl oz] per day) before and 10 months after implementation of an SSB sales ban in a large workplace, with half the employees randomized to receive a brief motivational intervention targeting SSB reduction. Interventions The employer stopped selling SSBs in all workplace venues, and half the sample was randomized to receive a brief motivational intervention and the other half was a control group that did not receive the intervention. This intervention was modeled on standard brief motivational interventions for alcohol used in the workplace that promote health knowledge and goal setting. Main Outcomes and Measures Outcomes included changes in SSB intake, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), and measures of abdominal adiposity. The primary associations tested were the correlation between changes in SSB intake and changes in HOMA-IR. Results Among the 214 study participants, 124 (57.9%) were women, with a mean (SD) age of 41.2 (11.0) years and a baseline mean (SD) body mass index of 29.4 (6.5). They reported a mean daily intake of 1050 mL (35 fl oz) of SSBs at baseline and 540 mL (18 fl oz) at follow-up-a 510-mL (17-fl oz) (48.6%) decrease (P < .001). Reductions in SSB intake correlated with improvements in HOMA-IR (r = 0.16; P = .03). Those not randomized to receive the brief intervention reduced their SSB intake by a mean (SD) of 246.0 (84.0) mL (8.2 [2.8] fl oz), while those also receiving the brief intervention reduced SSB intake by 762.0 (84.0) mL (25.4 [2.8] fl oz). From baseline to follow-up, there were significant reductions in mean (SE) waist circumference (2.1 [2.8] cm; P < .001). Conclusions and Relevance This study's findings suggest that the workplace sales ban was associated with a reduction in SSB intake and a significant reduction in waist circumference among employees within 10 months. The randomized clinical trial portion of this study found that targeting those at high risk with a brief motivational intervention led to additional improvements. Workplace sales bans may offer a promising new private-sector strategy for reducing the health harms of SSB intake.
机译:糖加饮料(SSB)摄入量的重要性可以改善健康,但对于个人来说很难自己实现。旨在评估工作场所SSB销售禁令是否与员工的SSB摄入和心脏异常健康有关,以及短暂的励志干预为销售禁令提供额外的福利。在2015年7月28日至2016年7月28日,北加州大学和医院评估的SSB摄入,人体测量学和214名全职英语中的Cardiforabolic Biomarkers之前,在2016年7月28日之前进行了设计,环境和参与者 - 在大型工作场所实施SSB销售禁令后,频繁SSB消费者(> =每天360毫升[> = 12FL盎司)的员工,随行有一半的员工接受短暂的激励干预针对SSB减少。干预员工在所有工作场所场地停止销售SSB,随机分组的一半,以获得短暂的激励干预,另一半是未获得干预的对照组。这种干预是根据促进健康知识和目标环境的工作场所使用的醇的标准短暂动机干预措施。主要结果和措施结果包括SSB摄入量的变化,胰岛素抵抗(HOMA-IR)的稳态模型评估,以及腹部肥厚的衡量标准。测试的主要关联是SSB摄入量变化与HOMA-IR的变化之间的相关性。结果214名研究参与者,124名(57.9%)是妇女,平均(SD)年龄为41.2(11.0)岁,基线平均(SD)体重指数为29.4(6.5)。他们报告了基线(35毫升)在基线和540ml(18倍盎司)的250ml(35次盎司)的平均摄入量,在510-mL(17-Fl Oz)(48.6%)下降(P <。 001)。减少SSB摄入量与HOMA-IR的改进相关(r = 0.16; p = .03)。未随机接受短暂干预的人将其SSB摄入量减少了246.0(84.0)毫升(8.2 [2.8] FL OZ)的平均值(SD),而那些也通过762.0(84.0)毫升(84.0)毫升( 25.4 [2.8] FL OZ)。从基线到随访中,平均(SE)腰围的显着减少(2.1 [2.8] cm; p <.001)。结论和相关性本研究表明,工作场所销售禁令与SSB摄入量减少有关,员工在10个月内的腰围大幅减少。本研究的随机临床试验部分发现,瞄准高风险的那些具有短暂的激励干预导致了额外的改进。工作场所销售禁令可能提供有希望的新私营部门,以减少SSB Intake的健康危害。

著录项

  • 来源
    《JAMA internal medicine》 |2020年第1期|共8页
  • 作者单位

    Univ Calif San Francisco Dept Psychiat San Francisco CA 94143 USA;

    Univ Calif San Francisco Ctr Hlth &

    Community 3333 Calif St Ste 465 San Francisco CA 94143 USA;

    Univ Calif San Francisco Philip R Lee Inst Hlth Policy Studies 3333 Calif St San Francisco CA;

    Univ Michigan Sch Publ Hlth Dept Nutr Sci Ann Arbor MI 48109 USA;

    Univ Calif San Francisco Osher Ctr Integrat Med San Francisco CA 94143 USA;

    Univ Calif San Francisco UCSF Wellness Program Campus Life Serv San Francisco CA 94143 USA;

    Univ Calif San Francisco UCSF Wellness Program Campus Life Serv San Francisco CA 94143 USA;

    Univ Calif San Francisco Ctr Hlth &

    Community 3333 Calif St Ste 465 San Francisco CA 94143 USA;

    Univ Calif San Francisco Dept Psychiat San Francisco CA 94143 USA;

    Univ Calif San Francisco Philip R Lee Inst Hlth Policy Studies 3333 Calif St San Francisco CA;

    Univ Calif Davis Dept Mol Biosci Davis CA 95616 USA;

    Univ Calif San Francisco Philip R Lee Inst Hlth Policy Studies 3333 Calif St San Francisco CA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 预防医学、卫生学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号